Numerous glucose-lowering medications have been developed in recent years with growing evidence relating to their efficacy and safety.

Complex regimens are challenging to administer and have been linked to non-adherence, medication errors and hospital admissions.

Medication review can be delivered using telehealth during the COVID-19 pandemic to ensure ongoing provision of care to vulnerable patient populations and to minimise risk of infection.

Immunosenescence, altered pharmacokinetics and the presence of multiple comorbidities can all affect response to immunosuppressants.

An open and engaging discussion will assist patients in making an informed decision on whether pre-exposure prophylaxis is suitable for them.

An individualised approach is needed to provide pre-travel health advice and immunisation.

Boosting hepatis C virus diagnosis and treatment in general practice settings for people who inject drugs is essential if Australia is to reach the World Health Organization elimination goals.